Novel Technology Platforms
Following are some of the technology platforms that are at a mature stage of development and approaching commercialization:
New Generation Rapid Diagnostics
JPM has re-developed the LFD format rapid diagnostic test leading to an increased sensitivity by at least 500 folds. As a result, JPM has the technical capabilities to turn any laboratory based test of the ELIZA format into a rapid field test with minimal loss of sensitivity. JPM has successfully used this patented platform to develop the world’s first combined antigen/antibody test for the early detection of HIV from an unprocessed blood sample, and is currently developing the world’s first practical tuberculosis test. This technology was developed and products are being manufactured under JPM’s AraGen subsidiary.
Bovine Pregnancy Rapid Diagnostic Test
JPM has developed the world’s first rapid diagnostic test for cow pregnancy. This technology was developed under JPM’s AraGen subsidiary.
Standardized Herbal Extract
Under the Delass subsidiary, JPM has successfully developed a number of standardized herbal extracts for use in herbal medicines and supplements. These new products are now undergoing scale-up manufacturing and will be available for purchase in the future.
